| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |